Skip to main content

US ClosedU.S. Closed

AARD: Aardvark Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments.

52W Range

17thpctl

Volume

0.63×avg

Market Cap

126.71MUSD

P/E Ratio

-1.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Aardvark Therapeutics, Inc. Common Stock

AARDNASDAQ Global Select·USD·Closed

Aardvark Therapeutics, Inc. Common Stock

AARDNASDAQ·USD·Closed

$5.79

−12.54%

$5.79

−$0.83 (12.54%)

52W Range

17thpctl

Volume

0.63×avg

Mkt Cap

126.71MUSD

P/E

-1.8TTM

Div Yield

–ann